These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 1713067

  • 1. Markers for hepatocellular carcinoma.
    Wu AH, Sell S.
    Immunol Ser; 1990; 53():403-22. PubMed ID: 1713067
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA, Gadelhak SA, El-Morsi DA, Abdelaziz MM, Abbas AT, El-Emshaty HM.
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [Abstract] [Full Text] [Related]

  • 3. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
    Shimizu A, Shiraki K, Ito T, Sugimoto K, Sakai T, Ohmori S, Murata K, Takase K, Tameda Y, Nakano T.
    Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
    [Abstract] [Full Text] [Related]

  • 4. [Screening for hepatocellular carcinoma].
    Leone N, Rizzetto M.
    Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
    [Abstract] [Full Text] [Related]

  • 5. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
    Aoyagi Y, Oguro M, Yanagi M, Mita Y, Suda T, Suzuki Y, Hata K, Ichii K, Asakura H.
    Cancer; 1996 May 01; 77(9):1781-6. PubMed ID: 8646674
    [Abstract] [Full Text] [Related]

  • 6. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG, Mathews S, Jayanthi V, Shankar EM, Hari R, Surendran R, Vengatesan A, Raghuram K, Rajasambandam P, Murali A, Srinivas U, Palaniswamy KR, Pugazhendhi T, Thyagarajan SP.
    Int J Infect Dis; 2008 Nov 01; 12(6):e71-6. PubMed ID: 18658001
    [Abstract] [Full Text] [Related]

  • 7. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.
    J Gastroenterol Hepatol; 2008 Oct 01; 23(10):1541-8. PubMed ID: 18422961
    [Abstract] [Full Text] [Related]

  • 8. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
    El-Aneed A, Banoub J.
    Anticancer Res; 2006 Oct 01; 26(5A):3293-300. PubMed ID: 17094443
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
    Cui R, Wang B, Ding H, Shen H, Li Y, Chen X.
    Chin Med J (Engl); 2002 Jan 01; 115(1):42-5. PubMed ID: 11930656
    [Abstract] [Full Text] [Related]

  • 10. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
    Peng YC, Chan CS, Chen GH.
    Hepatogastroenterology; 1999 Jan 01; 46(30):3208-11. PubMed ID: 10626187
    [Abstract] [Full Text] [Related]

  • 11. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study.
    McMahon BJ, Bulkow L, Harpster A, Snowball M, Lanier A, Sacco F, Dunaway E, Williams J.
    Hepatology; 2000 Oct 01; 32(4 Pt 1):842-6. PubMed ID: 11003632
    [Abstract] [Full Text] [Related]

  • 12. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W, Yao DF, Yuan YM, Fan JW, Lu XF, Li XH, Qiu LW, Zong L, Wu XH.
    Hepatobiliary Pancreat Dis Int; 2006 Nov 01; 5(4):538-44. PubMed ID: 17085339
    [Abstract] [Full Text] [Related]

  • 13. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
    Petry W, Heintges T, Hensel F, Erhardt A, Wenning M, Niederau C, Häussinger D.
    Z Gastroenterol; 1997 Dec 01; 35(12):1059-67. PubMed ID: 9487638
    [Abstract] [Full Text] [Related]

  • 14. [Clinical usefulness of lectin-reactive fraction of alpha-fetoprotein in hepatocellular carcinoma].
    Tamura A, Oita T, Sakizono K, Nakajima T, Kasakura S.
    Rinsho Byori; 1998 Feb 01; 46(2):158-62. PubMed ID: 9528340
    [Abstract] [Full Text] [Related]

  • 15. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
    Ishii M, Gama H, Chida N, Ueno Y, Shinzawa H, Takagi T, Toyota T, Takahashi T, Kasukawa R.
    Am J Gastroenterol; 2000 Apr 01; 95(4):1036-40. PubMed ID: 10763956
    [Abstract] [Full Text] [Related]

  • 16. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS, Park JW, Jang JS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK.
    J Clin Gastroenterol; 2009 Apr 01; 43(5):482-8. PubMed ID: 19197197
    [Abstract] [Full Text] [Related]

  • 17. [Clinical usefulness of plasma PIVKA-II assay and its limitations in patients with hepatocellular carcinoma].
    Fujiyama S, Morishita T, Shibata J, Sato T.
    Gan To Kagaku Ryoho; 1989 Apr 01; 16(4 Pt 2-1):1129-38. PubMed ID: 2471453
    [Abstract] [Full Text] [Related]

  • 18. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C, Wang Z, Liu L, Zhao P, Wang W, Yao D, Shi B, Lu J, Liao P, Yang Y, Zhu L.
    J Gastroenterol Hepatol; 2009 Jan 01; 24(1):55-62. PubMed ID: 18823443
    [Abstract] [Full Text] [Related]

  • 19. Alpha-fetoprotein in hepatocellular carcinoma: a serological and histochemical study in Malaysian patients.
    Yap SF, Peh SC.
    Malays J Pathol; 1991 Dec 01; 13(2):115-8. PubMed ID: 1726642
    [Abstract] [Full Text] [Related]

  • 20. Serum epoxide hydrolase (preneoplastic antigen) in human and experimental liver injury.
    Moody DE, Loury DN, Hammock BD, Ruebner BH, Cullen JM, Hillman JH, Hillman DW, Rao MS, London WT, Hann HW.
    Cancer Epidemiol Biomarkers Prev; 1992 Dec 01; 1(5):395-403. PubMed ID: 1339049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.